Studies indicate that many tumors have overexpression of cyclin D1, such as mantle cell lymphoma (CML), nonsmall cell lung cancer (NSCLC), breast cancer, head and neck cancer, and esophageal cancer [20, 21]. Here, CCND1 is linked to lung cancer.